Study of Marham Kharish Jadeed (Unani Drug) in Ringworm
- Conditions
- Health Condition 1: null- QUBA (TINEA CORPORIS)
- Registration Number
- CTRI/2017/12/010995
- Lead Sponsor
- Central Research Institute of Unani Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 60
1.Patients having Quba (Tinea corporis) with the following signs and symptom:
a.Itching
b.Erythema
c.Scaling of lesion
d.Central clearing with peripheral raised margins
2.Patients with a mycological diagnosis of Tinea Corporis confirmed by microscopic KOH wet mount
1.All other clinical types of tinea infections
2.Patients with secondary bacterial infections/ Diabetes Mellitus
3.Pregnant and lactating women
4.Significant Pulmonary/Cardiovascular/Hepato-renal Dysfunction
5.Known cases of Immunocompromised states (HIV/ AIDS, etc.)
6.History of hypersensitivity to Terbinafine and Marham Kharish Jadeed
7.Patients using the following medications:
8.Topical antifungal agent/ topical corticosteroids in treatment area within 30 days of baseline visit
9.Systemic anti-fungals within 8 weeks of baseline visit (8 months for oral Terbinafine)
10.Systemic corticosteroids within 30 days of baseline visit
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method